tiprankstipranks
Fine Foods & Pharmaceuticals N.T.M. SpA (IT:FF)
:FF
Italy Market
Want to see IT:FF full AI Analyst Report?

Fine Foods & Pharmaceuticals N.T.M. SpA (FF) Price & Analysis

7 Followers

FF Stock Chart & Stats

€9.40
€0.00(0.00%)
At close: 4:00 PM EST
€9.40
€0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Recovered And Stable ProfitabilityThe company has moved from losses to a consistent mid-single-digit operating margin and a positive net margin, indicating an operational turnaround. Sustained modest profitability improves capacity to fund operations, supports creditor confidence, and underpins longer-term reinvestment and dividend potential.
Moderate Leverage And Improved Balance-sheet ResilienceLeverage has declined materially from earlier peaks, leaving a moderate debt burden relative to equity. A stronger capital structure reduces refinancing risk, gives management flexibility for strategic investments or buffer in downturns, and supports continued recovery without immediate solvency pressure.
Diversified Revenue Model: CDMO + DistributionOperating both contract manufacturing services and commercial distribution creates revenue diversification across fee-based manufacturing and product sales. This dual model smooths cash flow sources, leverages manufacturing capacity, and provides cross-selling opportunities that support durable revenue resilience.
Bears Say
Negative Free Cash FlowPersistent negative free cash flow despite positive operating cash generation implies reinvestment needs or working-capital strain are consuming cash. Over months this reduces capacity to pay down debt or expand without external funding, raising execution and liquidity risk for strategic initiatives.
Choppy Revenue MomentumRevenue has fluctuated year-to-year with strong 2023, a decline in 2024, modest 2025 growth and a slight TTM decline. This inconsistent top-line trajectory undermines predictability for capacity planning and margins, complicating long-term investment and forecasting decisions.
Volatile Gross-profit ProfileLarge swings in gross profit margins suggest cost volatility, pricing pressure, or non-comparable reporting items. Persistent margin volatility weakens margin sustainability, complicates margin planning and may indicate exposure to input-cost swings or uneven contract mix that could erode long-term profitability.

FF FAQ

What was Fine Foods & Pharmaceuticals N.T.M. SpA’s price range in the past 12 months?
Fine Foods & Pharmaceuticals N.T.M. SpA lowest stock price was €7.62 and its highest was €11.90 in the past 12 months.
    What is Fine Foods & Pharmaceuticals N.T.M. SpA’s market cap?
    Fine Foods & Pharmaceuticals N.T.M. SpA’s market cap is €222.43M.
      When is Fine Foods & Pharmaceuticals N.T.M. SpA’s upcoming earnings report date?
      Fine Foods & Pharmaceuticals N.T.M. SpA’s upcoming earnings report date is Sep 08, 2026 which is in 58 days.
        How were Fine Foods & Pharmaceuticals N.T.M. SpA’s earnings last quarter?
        Fine Foods & Pharmaceuticals N.T.M. SpA released its earnings results on May 07, 2026. The company reported €0.036 earnings per share for the quarter, beating the consensus estimate of N/A by €0.036.
          Is Fine Foods & Pharmaceuticals N.T.M. SpA overvalued?
          According to Wall Street analysts Fine Foods & Pharmaceuticals N.T.M. SpA’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
            Does Fine Foods & Pharmaceuticals N.T.M. SpA pay dividends?
            Fine Foods & Pharmaceuticals N.T.M. SpA pays a Annually dividend of €0.16 which represents an annual dividend yield of 1.48%. See more information on Fine Foods & Pharmaceuticals N.T.M. SpA dividends here
              What is Fine Foods & Pharmaceuticals N.T.M. SpA’s EPS estimate?
              Fine Foods & Pharmaceuticals N.T.M. SpA’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does Fine Foods & Pharmaceuticals N.T.M. SpA have?
              Fine Foods & Pharmaceuticals N.T.M. SpA has 22,060,125 shares outstanding.
                What happened to Fine Foods & Pharmaceuticals N.T.M. SpA’s price movement after its last earnings report?
                Fine Foods & Pharmaceuticals N.T.M. SpA reported an EPS of €0.036 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -9.149%.
                  Which hedge fund is a major shareholder of Fine Foods & Pharmaceuticals N.T.M. SpA?
                  Currently, no hedge funds are holding shares in IT:FF
                  What is the TipRanks Smart Score and how is it calculated?
                  Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                    Company Description

                    Fine Foods & Pharmaceuticals N.T.M. SpA

                    Fine Foods & Pharmaceuticals N.T.M. S.p.A. functions as a contract development and manufacturing organization (CDMO), specializing in the creation of various oral solid forms for the pharmaceutical and nutraceutical sectors. Its pharmaceutical offerings include items such as powders, granules, capsules, standard and film-coated tablets, effervescent granules, and hard gelatine capsules. For the nutraceutical market, the company produces soluble, effervescent, and chewable tablets, fast-melting/sublingual tablets, film-coated tablets, and hard gelatine capsules, alongside soluble and effervescent powders and granules. These nutraceutical products are designed to support a wide range of health needs, encompassing areas like probiotics, multivitamins and minerals, immune system function, sleep and relaxation, gastrointestinal and circulatory health, osteoarticular and urinary systems, women's health, beauty, healthy aging, and mental wellbeing. In addition to its core CDMO services, the company also manufactures and sells a diverse array of cosmetic products, covering hair care, skin care, liquid personal hygiene items, oral hygiene products, deodorants, alcohol-based perfumery, bath and shower gels, shampoos and conditioners, shaping waxes, mouthwashes, creams, gels, and toothpastes. Furthermore, they supply medical surgical aids and devices, various antiseptics for intact skin, hand sanitizers, pre-injection solutions, hydroalcoholic surface cleaners, and iodine. Their product line also extends to orthodontic cleaning tablets, disinfectants, and decongestant nasal sprays. Established in 1984, the company is headquartered in Verdellino, Italy.

                    Fine Foods & Pharmaceuticals N.T.M. SpA (FF) Earnings & Revenues

                    FF Stock 12 Month Forecast

                    Average Price Target

                    €13.43
                    ▲(42.91% Upside)
                    {"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"6":"€6","15":"€15","8.25":"€8.25","10.5":"€10.5","12.75":"€12.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":14.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€14.50</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":13.433333333333334,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€13.43</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":12.8,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€12.80</span>\n  </div></div>","useHTML":true}}],"tickPositions":[6,8.25,10.5,12.75,15],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.66,9.10923076923077,9.558461538461538,10.007692307692308,10.456923076923077,10.906153846153845,11.355384615384615,11.804615384615385,12.253846153846155,12.703076923076923,13.152307692307692,13.60153846153846,14.05076923076923,{"y":14.5,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.66,9.027179487179488,9.394358974358974,9.761538461538462,10.128717948717949,10.495897435897437,10.863076923076923,11.23025641025641,11.597435897435897,11.964615384615385,12.331794871794871,12.69897435897436,13.066153846153846,{"y":13.433333333333334,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,8.66,8.978461538461538,9.296923076923077,9.615384615384615,9.933846153846154,10.252307692307692,10.570769230769232,10.88923076923077,11.207692307692309,11.526153846153846,11.844615384615386,12.163076923076924,12.481538461538463,{"y":12.8,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":7.863,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":7.529,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.571,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.551,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.141,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.2,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.416,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.124,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":11.451,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.551,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":9.24,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.84,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.66,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
                    Similar Stocks
                    Company
                    Price & Change
                    Follow
                    Valsoia SpA
                    Enervit S.p.A.
                    Italian Wine Brands S.p.A.
                    Laboratorio Farmaceutico Erfo SpA
                    NewPrinces S.p.A.

                    Options Prices

                    Currently, No data available
                    ---
                    Popular Stocks